Owens and Minor
we have some technical reasons here.
1. RSI divergence on the weekly chart: 2025 Februar and April made a doubla bottom formation, with higher RSI in April
2. $6.88 is a year S1 pivot level
3. At $14.1 is a gap wacthing us, promising a 100% upside potential
Fundamental reasons:
1. The whole healthcare sector is down because US government, can be a good contrarian play for 2025 or 2026
2. This spring, Coliseum Capital management bought around 4M Shares, and now holding 31% of the company.
The share price can decline further, breaking the $6.0 level for a short period of time. But it didn't happened in the April panic. $ 5.89 can be a good stop-loss level alltough if you can handle -18% loss.
But i'm waiting for upside momentum in OMI.
we have some technical reasons here.
1. RSI divergence on the weekly chart: 2025 Februar and April made a doubla bottom formation, with higher RSI in April
2. $6.88 is a year S1 pivot level
3. At $14.1 is a gap wacthing us, promising a 100% upside potential
Fundamental reasons:
1. The whole healthcare sector is down because US government, can be a good contrarian play for 2025 or 2026
2. This spring, Coliseum Capital management bought around 4M Shares, and now holding 31% of the company.
The share price can decline further, breaking the $6.0 level for a short period of time. But it didn't happened in the April panic. $ 5.89 can be a good stop-loss level alltough if you can handle -18% loss.
But i'm waiting for upside momentum in OMI.
Trade attivo
Bought at 7.22Nota
OWENS & MINOR AND ROTECH HEALTHCARE MUTUALLY AGREE TO TERMINATE PREVIOUSLY ANNOUNCED ACQUISITIONOWENS & MINOR INC - TO REDEEM $1 BILLION NOTES ISSUED IN APRIL 2025
Nota
+20% week, let's see.Trade chiuso: stop raggiunto
-33% day
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.